Exchange: NASDAQ·Updated 01:05 PM EDT

AVLN Avalyn Pharma Inc.

$36.63
$1.19
(3.36%)
Today
EarningsNov 16
Mkt Cap$1.57B
Vol72,516.00

About AVLN

Avalyn Pharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). The company was founded by Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar on May 27, 2011 and is headquartered in Boston, MA.
52

Neutral Sentiment

How do you feel about AVLN?

Advertisement|Remove ads.